Symbol="CERE"
AssetType="Common Stock"
Name="Cerevel Therapeutics Holdings Inc"
Description="Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various therapies for neuroscientific diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="1805387"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="131 DARTMOUTH STREET, SUITE 502, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3387593000"
EBITDA="-393470016"
PERatio="None"
PEGRatio="None"
BookValue="2.227"
DividendPerShare="0"
DividendYield="0"
EPS="-2.64"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.334"
ReturnOnEquityTTM="-0.987"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.64"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="34.13"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="6.96"
EVToRevenue="-"
EVToEBITDA="-11.68"
Beta="1.361"
num_52WeekHigh="35.98"
num_52WeekLow="20.49"
num_50DayMovingAverage="30.26"
num_200DayMovingAverage="29.39"
SharesOutstanding="156833000"
DividendDate="None"
ExDividendDate="None"
symbol="CERE"
open="22.15"
high="22.15"
low="21.08"
price="22.00"
volume="684161.00"
latest_trading_day="2023-08-14"
previous_close="22.04"
change="-0.04"
change_percent="-0.1815%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="50"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="50"
Volume_recent_avg="600945"
Change_recent_avg="-0.04"
Delta_recent_avg="1.25"
Variance_recent_avg="0.62"
Change_ratio_recent_avg="-0.22"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_10"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="50"
Aroon_momentum_negative="50"
image_negative_thumbnail_id_1="93"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0083.jpeg"
image_negative_thumbnail_id_2="1106"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0139.jpeg"
image_neutral_thumbnail_id_1="522"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0077.jpeg"
image_neutral_thumbnail_id_2="596"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_positive_thumbnail_id_1="696"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0012.jpeg"
image_positive_thumbnail_id_2="993"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0155.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
